Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
All-in-one Hangzhou Protocol: killing four birds with one stone
Cell Research ( IF 28.1 ) Pub Date : 2024-05-31 , DOI: 10.1038/s41422-024-00983-8 Haopeng Wang 1, 2, 3 , Shizhen Qiu 1, 4 , Mohamad Mohty 5
中文翻译:
多合一杭州协议:一石四鸟
更新日期:2024-05-31
Cell Research ( IF 28.1 ) Pub Date : 2024-05-31 , DOI: 10.1038/s41422-024-00983-8 Haopeng Wang 1, 2, 3 , Shizhen Qiu 1, 4 , Mohamad Mohty 5
Affiliation
In a recent study published in The New England Journal of Medicine, researchers developed an innovative “all-in-one” treatment protocol that combines CD7 chimeric antigen receptor T-cell therapy with subsequent haploidentical hematopoietic stem cell transplantation. This approach significantly advances the treatment of CD7+ hematological malignancies by eliminating the need for myeloablative chemotherapy and immunosuppressants for graft-versus-host disease prophylaxis.
中文翻译:
多合一杭州协议:一石四鸟
在最近发表在《新英格兰医学杂志》上的一项研究中,研究人员开发了一种创新的“一体化”治疗方案,将 CD7 嵌合抗原受体 T 细胞疗法与随后的半相合造血干细胞移植相结合。这种方法无需清髓性化疗和免疫抑制剂来预防移植物抗宿主病,从而显着推进了 CD7 + 血液系统恶性肿瘤的治疗。